Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dianthus Therapeutics, Inc.(DNTH) | 2,341,667 | 2,341,667 | 0 | $42.48M | $43.63M | 9.57% | +$1.15M |
| ArriVent BioPharma, Inc.(AVBP) | 2,059,387 | 1,946,054 | -113,333 | $38.08M | $42.37M | 9.30% | +$4.29M |
| Verona Pharma PlcADS | 217,264 | 337,000 | +119,736 | $13.79M | $31.87M | 7.00% | +$18.08M |
| Taysha Gene Therapies, Inc.(TSHA) | 10,700,000 | 12,592,500 | +1,892,500 | $14.87M | $29.09M | 6.38% | +$14.22M |
| ARS Pharmaceuticals, Inc.(SPRY) | 625,000 | 1,350,000 | +725,000 | $7.86M | $23.56M | 5.17% | +$15.70M |
| Gossamer Bio, Inc.(GOSS) | 18,350,000 | 18,350,000 | 0 | $20.18M | $22.57M | 4.95% | +$2.39M |
| Ocular Therapeutix, Inc.(OCUL) | 2,425,000 | 2,425,000 | 0 | $17.78M | $22.50M | 4.94% | +$4.73M |
| Merus N V | 308,000 | 389,000 | +81,000 | $12.96M | $20.46M | 4.49% | +$7.50M |
| Trevi Therapeutics, Inc.(TRVI) | 3,322,000 | 3,672,000 | +350,000 | $20.90M | $20.09M | 4.41% | -$809.5K |
| Cogent Biosciences, Inc.(COGT) | 2,763,000 | 2,763,000 | 0 | $16.55M | $19.84M | 4.35% | +$3.29M |
| Atyr Pharma Inc | 3,552,000 | 3,820,000 | +268,000 | $10.73M | $19.37M | 4.25% | +$8.64M |
| Apellis Pharmaceuticals Inc COM | 2,094,000 | 903,500 | -1,190,500 | $45.80M | $15.64M | 3.43% | -$30.16M |
| Nuvation Bio Inc.CL A(NUVB) | 7,900,000 | 7,691,334 | -208,666 | $13.90M | $15.00M | 3.29% | +$1.09M |
| Tourmaline Bio Inc | 905,000 | 905,000 | 0 | $13.77M | $14.47M | 3.18% | +$705.9K |
| Kalvista Pharmaceuticals Inc | 1,370,000 | 1,273,333 | -96,667 | $15.81M | $14.40M | 3.16% | -$1.41M |
| Mind Medicine Mindmed Inc | 3,018,000 | 2,130,000 | -888,000 | $17.66M | $13.82M | 3.03% | -$3.83M |
| Centessa Pharmaceuticals PlcADS | 1,425,000 | 1,030,000 | -395,000 | $20.49M | $13.53M | 2.97% | -$6.96M |
| Pharvaris N V COM | 769,815 | 672,595 | -97,220 | $12.09M | $11.84M | 2.60% | -$248.4K |
| Kymera Therapeutics, Inc.(KYMR) | 0 | 266,000 | +266,000 | $0 | $11.61M | 2.55% | +$11.61M |
| ABIVAX Société AnonymeADS(ABVX) | 1,230,000 | 1,267,000 | +37,000 | $7.69M | $9.69M | 2.13% | +$2.01M |
| DBV Technologies S.A.ADS(DBVT) | 0 | 1,018,021 | +1,018,021 | $0 | $9.31M | 2.04% | +$9.31M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 1,115,000 | 1,115,000 | 0 | $5.92M | $7.69M | 1.69% | +$1.77M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 296,000 | 148,000 | -148,000 | $11.56M | $6.99M | 1.53% | -$4.58M |
| Unicycive Therapeutics, Inc.(UNCY) | 0 | 1,000,000 | +1,000,000 | $0 | $4.77M | 1.05% | +$4.77M |
| Neurogene Inc.(NGNE) | 303,000 | 303,000 | 0 | $3.55M | $4.53M | 0.99% | +$981.7K |
| Helix Acquisition Corp IiCL A | 250,000 | 250,000 | 0 | $2.83M | $2.66M | 0.58% | -$162.5K |
| Maze Therapeutics, Inc.(MAZE) | 468,000 | 177,667 | -290,333 | $5.15M | $2.18M | 0.48% | -$2.97M |
| Kalaris Therapeutics, Inc.(KLRS) | 481,000 | 360,000 | -121,000 | $3.86M | $961.2K | 0.21% | -$2.90M |
| Erasca, Inc.(ERAS) | 5,136,795 | 700,000 | -4,436,795 | $7.04M | $889.0K | 0.20% | -$6.15M |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 27,330,800 | 154,112 | -27,176,688 | $48.10M | $300.5K | 0.07% | -$47.80M |
| Verastem, Inc.(VSTM) | 1,720,000 | 0 | -1,720,000 | $10.37M | $0 | — | -$10.37M |
| Perspective Therapeutics, Inc.(CATX) | 2,250,000 | 0 | -2,250,000 | $4.79M | $0 | — | -$4.79M |
| Regulus Therapeutics Inc | 4,637,076 | 0 | -4,637,076 | $8.11M | $0 | — | -$8.11M |
| Scholar Rock Holding Corporation(SRRK) | 329,000 | 0 | -329,000 | $10.58M | $0 | — | -$10.58M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 904,000 | 0 | -904,000 | $11.11M | $0 | — | -$11.11M |
| Unicycive Therapeutics Inc | 10,000,000 | 0 | -10,000,000 | $5.75M | $0 | — | -$5.75M |
| Taysha Gene Therapies Inc | 10,700,000 | 0 | -10,700,000 | $14.87M | $0 | — | -$14.87M |
| Viridian Therapeutics, Inc.(VRDN) | 450,000 | 0 | -450,000 | $6.07M | $0 | — | -$6.07M |
| ImmunityBio, Inc.(IBRX) | 1,720,000 | 0 | -1,720,000 | $10.37M | $0 | — | -$10.37M |
| Humacyte, Inc.ADS(HUMA) | 217,264 | 0 | -217,264 | $13.79M | $0 | — | -$13.79M |
| Capricor Therapeutics, Inc.(CAPR) | 450,000 | 0 | -450,000 | $6.07M | $0 | — | -$6.07M |